¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gray substance of spinal cord"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • spinal animal
    ô¼öµ¿¹°
  • spinal arachnoid
    ô¼ö°Å¹Ì¸·, ô¼öÁöÁÖ¸·
  • spinal artery
    ô¼öµ¿¸Æ
  • spinal automatism
    ô¼öÀÚµ¿Áõ
  • spinal canal
    ôÁÖ°ü
  • spinal caries
    ôÃß°áÇÙ
  • spinal column
    ôÁÖ
  • spinal evoked potential
    ô¼öÀ¯¹ßÀüÀ§
  • spinal fusion
    ôÃßÀ¯ÇÕ(¼ú)
  • spinal ganglion
    ô¼ö½Å°æÀý
  • spinal headache
    ôÃ߸¶ÃëµÎÅë
  • spinal lemniscus
    ô¼ö¼¶À¯¶ì, ô¼ö¼¶À¯´ë
  • spinal leptomeningitis
    ô¼ö¿¬¼ö¸·¿°
  • spinal meningitis
    ô¼ö¸·¿°
  • spinal meningocele
    ô¼ö¸·Å»Ãâ(Áõ), ô¼ö¸··ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • accessory food substance
    ºÎ¿µ¾ç¹°Áú
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º¹°Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú
  • antithyroid substance
    Ç×¹æÆÐ»ù¹°Áú, Ç×°©»ó»ù¹°Áú
  • antiyeast substance
    Ç×È¿¸ð¹°Áú
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
  • cement substance
    Á¢ÇÕÁú
  • chromophil substance
    (¢¡Nissl body) ´Ö½½¼Òü
  • compact substance
    Ä¡¹ÐÁú
  • conjugated estrogenic substance
    Á¢ÇÕ¹ßÁ¤¹°Áú
  • cortical substance
    °ÑÁú, ÇÇÁú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
  • accessory food substance
    ºÎ¿µ¾ç¹°(Üùç½å×Úª).
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º ¹°Áú(ëêó¢àõÚªòõ).
  • anterior perforated substance
    ¾Õ°üÅëÁú
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • antibacterial substance
    Ç×±Õ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú.
  • antimold (substance)
    Ç×°õÆÎÀÌ(¹°Áú).
  • antithyroid substance
    Ç×°©»ó¼±¹°Áú.
  • antiyeast substance
    Ç×È¿¸ð¹°Áú.
  • gelatinous substance
    ¾ÆaÁú, a¾çÁú(ÎïåÆòõ).
  • gelatinous substance
    ¾Æ±³Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • false glottis =false cord
    °¡¼º¹®, °¡¼º´ë
  • false vocal cord
    °¡¼º´ë(Ê£á¢Óá) ÀüÁ¤Ãߺ® .
  • fibrous cord
    ¼¶À¯²ö, ¼¶À¯´ë(àéë«Óá).
  • fibrous cord
    ¼¶À¯²ö
  • forelying of umbilical cord
    Á¦´ëÇϼö(ð°Óá ù»á÷).
  • ganglionated cord
    a°¨½Å°æ»è.
  • ganglionated cord
    ±³°¨½Å°æ»è.
  • genital cord
    »ý½Ä»è(ßæãÖßã).
  • glottis, false =false cord
    °¡¼º¹®, °¡¼º´ë
  • hepatic cell cord
    °£¼¼Æ÷ÁÙ, °£¼¼Æ÷»è(¡­ßã).
  • hepatic cord
    °£¼¼Æ÷ÁÙ, °£¼¼Æ÷»è(ÊÜá¬øàßã).
  • hydrocele of cord
    Á¤»è¼öÁ¾.
  • insertion variations of umbilical cord
    ÅÈÁÙºÎÂøº¯ÀÌ
  • lateral cord
    °¡ÂʽŰæ´Ù¹ß
  • lateral cord and associated anterior cornual syndrome
    Ãø»èµ¿ÃøÀü°¢ÁõÈıº (ö°ßãÔÒö°îñÊÇñøý¦ÏØ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
BAVCP bilateral abductor vocal cord paralysis
CBL circulating blood lymphocytes; chronic blood loss; cord blood leukocytes
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CCT carotid compression tomography; central conduction time; cerebrocranial trauma; chocolate-coated tab...
CORD Commissioned Officer Residency Deferment; Council of Residency Directors
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
vlPAG ventrolateral periaquaductal gray
125I-BHSP 125I-Bolton Hunter substance P
TBARS 2-thiobarbituric acid-reacting substance
AS Aggregation substance
CDS Clonidine displacing substance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • spinal pathway
    ô¼ö °æ·Î
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • spinal reflex
    ô¼ö ¹Ý»ç
    ³ú¿Í ô¼ö »çÀ̸¦ Àý´ÜÇÑ ½ÇÇè µ¿¹°À» ô¼ö µ¿¹°À̶ó°í Çϸç, ÀÌ Ã´¼ö µ¿¹°¿¡¼­ º¼ ¼ö ÀÖ´Â ¹Ý»ç ±â´ÉÀ» ô¼ö ¹Ý»ç¶ó°í ÇÑ´Ù. ¿¹¸¦ µé¸é, ¿¡¼­ ³ú¿Í ô¼ö »çÀ̸¦ Àý´ÜÇÑ Ã´¼ö °³±¸¸®¿¡ ÃÊ»êÀ» ¹Ù¸¥ Á¾À̸¦ ´Ù¸®¿¡ ºÙÀ̸é ÀÚ±ØÀ» ¹Þ¾Æ ´Ù¸®¸¦ ¿òÃ÷¸°´Ù. ¿îµ¿°èÀÇ ¹Ý»ç·Î¼­´Â »çÁöÀÇ ±ÙÀ» ½ÅÀå½ÃŰ¸é ±× ±ÙÀÌ ¼öÃàÇÏ´Â ½ÅÀå ¹Ý»ç¿Í ÇǺθ¦ ÀÚ±ØÇßÀ» ¶§ »çÁö°¡ ¸öÅë ÂÊÀ¸·Î ±Á¾îÁö´Â ±¼±Ù ¹Ý»ç°¡ ÀÖ´Ù. ½ÅÀå ¹Ý»çÀÇ ¼ö¿ë±â´Â ±Ù ¼Ó¿¡ ÀÖ´Â ±Ù¹æÃßÀε¥, À̰ÍÀÌ ½ÅÀåµÇ¸é ±¸½É¼º Ãæ°ÝÀ» ÀÏÀ¸ÄÑ Ã´¼ö ÁßÃß¿¡¼­ ÀüȯµÇ¾î ¿îµ¿ ½Å°æ¿¡ Àü´ÞµÇ°í, °á±¹ ½ÅÀåµÇ¾ú´ø ±ÙÀÌ ¼öÃàÇÏ´Â ¹Ý»çÀÌ´Ù. ±ÙÀÌ ½ÅÀåµÇ¾î ±æ°Ô ´Ã¾î³ª¸é ¼öÃàÇÏ¿© ±× ±æÀ̸¦ ¿ø·¡´ë·Î µÇµ¹¸®´Â ÀÛ¿ëÀ» ÇÏ´Â °ÍÀ¸·Î¼­, ±ÙÀÇ ±æÀ̸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ´Â ¹Ý»ç¶ó°íµµ ÇÒ ¼ö ÀÖ´Ù. °üÀý Çϳª¿¡´Â ½Å±Ù°ú ±¼±ÙÀÌ Àִµ¥ µÑ ´Ù ½ÅÀå ¹Ý»ç°¡ ÀÖ¾î ±ÙÀÇ ±æÀ̸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇϱ⠶§¹®¿¡ °üÀýÀÌ °íÁ¤µÇ´Â °ÍÀÌ´Ù. ¹°·Ð ô¼ö µ¿¹°¿¡¼­´Â ¾ÆÁ÷ ½Å±Ù°ú ±¼±Ù°úÀÇ ½ÅÀå ¹Ý»ç¸¦ ÅëÇÕÇÒ ¼ö°¡ ¾øÀ¸¹Ç·Î ³ú°£ÀÇ ÅëÇÕ¿¡ ÀÇÇØ¼­¸¸ ºñ·Î¼Ò °üÀýÀÌ °íÁ¤µÇ°í ÀÚ¼¼¸¦ À¯ÁöÇÒ ¼ö ÀÖ°Ô µÈ´Ù. ±¼°î ¹Ý»ç´Â ÇǺηκÎÅÍÀÇ ±¸½É¼º Ãæ°ÝÀÌ Ã´¼öÀÇ ¹Ý»ç ÁßÃß¿¡¼­ »çÁöÀÇ ±¼±Ù¿¡ ÀÖ´Â ¿îµ¿ ½Å°æÀ¸·Î Àü´ÞµÇ´Â ¹Ý»çÀÌ´Ù. ¶ß°Å¿î °Í¿¡ ¼ÕÀÌ ´êÀ¸¸é ¹Ý»çÀûÀ¸·Î ±× ¼ÕÀ» ¿À¹Ç¸®´Â ÀÛ¿ëÀ» ÇÑ´Ù. ô¼ö¿¡´Â ÀÌ ¹Û¿¡µµ ÀÚÀ²½Å°æ ¹Ý»ç ÁßÃß°¡ ÀÖ´Ù. ¿¹ÄÁ´ë ¹è´¢ ÁßÃß, ¹èº¯ ÁßÃß¿Í ±× ¹Û¿¡ ºÒ¿ÏÀüÇÑ lÂ÷ ÁßÃ߷μ­ ¹ßÇÑ, Á¥ ºÐºñ, ½ÉÀå ¹Úµ¿ ÃËÁø, Ç÷°ü ¼öÃà µîÀ» ÀÏÀ¸Å²´Ù
  • spinal segment
    ô¼ö ºÐÀý
    1. ô¼ö´Â °¢ À§Ä¡¿¡ µû¶ó Å©±â¿Í ÇüÅÂ, ȸ¹éÁú°ú ¹éÁúÀÇ »ó´ëÀûÀÎ ¾ç, ±×¸®°í ȸ¹éÁúÀÇ ¹è¿­ÀÌ ´Ù¾çÇÏ°Ô ³ªÅ¸³­´Ù. 2. °æºÎÂÊÀ¸·Î ¿Ã¶ó°¥¼ö·Ï ¸ð¾çÀº ±¸Çü¿¡¼­ Ÿ¿øÇüÀ¸·Î º¯Çϰí, ȸ¹éÁúÀÇ »ó´ëÀûÀÎ ¾çµµ ÁÙ¾îµé¾î ¹éÁúÀÇ ¾çÀÌ »ó´ëÀûÀ¸·Î ¸¹¾ÆÁø´Ù.
  • spinal tap
    ô¼ö õÀÚ
  • spinal thalamic pathway
    ô¼ö ½Ã»ó·Î
  • spinal trigeminal nucleus
    »ïÂ÷ ½Å°æ ô¼ö ÇÙ, »ïÂ÷ ½Å°æ ô¼ö °¨°¢ ÇÙ
    ³ú±³, ¿¬¼ö ¹×, °æÃß C1, C2, C3¿¡ ÀÖÀ¸¸ç,
  • spinal veins
    ô¼ö Á¤¸Æ
  • total spinal anesthesia
    Àü ôÃß ¸¶Ãë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
mullerian inhibiting substance A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin.
Synonym: mullerian inhibiting factor.
(05 Mar 2000)
muscular substance of prostate The smooth muscle in the stroma of the prostate.
Synonym: substantia muscularis prostatae, musculus prostaticus.
(05 Mar 2000)
controlled substance A substance subject to the Controlled Substances Act (1970), which regulates the prescribing and dispensing, as well as the manufacturing, storage, sale, or distribution of substance's assigned to five schedules according to their 1) potential for or evidence of abuse, 2) potential for psychic or physiologic dependence, 3) contributing a public health risk, 4) harmful pharmacologic effect, or 5) role as a precursor of other controlled substance's.
(05 Mar 2000)
cortical substance The superficial thin layer of compact bone.
Synonym: substantia corticalis, cortical substance.
(05 Mar 2000)
posterior perforated substance The bottom of the interpeduncular fossa at the base of the midbrain, extending from the anterior border of the pons forward to the mamillary bodies, and containing numerous openings for the passage of perforating branches of the posterior cerebral arteries.
Synonym: substantia perforata posterior, locus perforatus posticus, Malacarne's space.
(05 Mar 2000)
pressor substance One of several products of intestinal putrefaction believed to cause functional hypertension when absorbed, any alkaline substance that raises blood pressure.
Synonym: pressor amine, pressor substance.
(05 Mar 2000)
proper substance See: substantia propria of cornea, substantia propria membranae tympani, substantia propria sclerae.
(05 Mar 2000)
schwann's white substance <anatomy> The substance of the medullary sheath.
Source: Websters Dictionary
(01 Mar 1998)
psychoses, substance-induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
(12 Dec 1998)
sensitizing substance Antibody that combines with and sensitises antigen leading to the activation of complement, which may result in cell lysis.
Synonym: CF antibody, sensitizing substance.
(05 Mar 2000)
h substance <haematology> A polysaccharide precursor molecule which is used to make the antigens on the surface of human blood cells that are classified in the ABO blood group system.
(09 Oct 1997)
slow-reacting substance Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules.
Compare: peptidyl leukotrienes.
Synonym: slow-reacting factor of anaphylaxis.
(05 Mar 2000)
slow reacting substance of anaphylaxis <immunology> Potent bronchoconstrictor and inflammatory agent released by mast cells, an important mediator of allergic bronchial asthma.
A mixture of three leukotrienes (LTC4 mainly, LTD4 and LTE4)
(18 Nov 1997)
soluble specific substance A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule.
Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar.
(05 Mar 2000)
specific capsular substance A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule.
Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á